Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

“Token” Consulting Arrangements Need Attention, AMA Rep Says

Executive Summary

"Token" consulting arrangements are one area that still needs attention from manufacturers and the medical community, a member of the AMA working group on gifts to physicians said

You may also be interested in...



Rx Consulting Agreements Must Address “Legitimate Need” – PhRMA Rules

PhRMA's definition of a bona fide consulting agreement requires that the services be pre-identified and address a legitimate need of the sponsor

Rx Consulting Agreements Must Address “Legitimate Need” – PhRMA Rules

PhRMA's definition of a bona fide consulting agreement requires that the services be pre-identified and address a legitimate need of the sponsor

PhRMA Marketing Code Prohibits Personal Gifts To Physician

The Pharmaceutical Research & Manufacturers of America marketing code includes an explicit prohibition on "items intended for the personal benefit of healthcare professionals.

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

PS039516

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel